Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehara

Showing results (331-340 of 378) with videos related to

Pageof 38
Sort By:
Biomedicines|February 24, 2024
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate CancerHiroshi Kano, Kouji Izumi, Ryunosuke Nakagawa, et al.
Journal of Medical Virology|December 25, 2010
Etiological role of human papillomavirus infection for inverted papilloma of the bladderKazuyoshi Shigehara, Toshiyuki Sasagawa, John Doorbar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 14, 2018
Etiological role of human papillomavirus infection in the development of penile cancerJiro Sakamoto, Kazuyoshi Shigehara, Kazufumi Nakashima, et al.
Urology Journal|December 20, 2021
Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECISTYoshifumi Kadono, Shohei Kawaguchi, Takahiro Nohara, et al.
Cancers|October 14, 2022
Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese MenRyunosuke Nakagawa, Hiroaki Iwamoto, Tomoyuki Makino, et al.
Anticancer Research|March 31, 2021
Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial CarcinomaYoshifumi Kadono, Shohei Kawaguchi, Takahiro Nohara, et al.
Cancers|February 9, 2020
Reply to Comment on "Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis" Cancers 2020 12, 89Suguru Kadomoto, Kouji Izumi, Kaoru Hiratsuka, et al.
Medical Molecular Morphology|March 14, 2025
Large number of CD68<sup>+</sup>/CD163<sup>+</sup> Hofbauer cells and characteristic vascular structural alterations in the placental villi of cases with placenta accreta spectrumHazuki Kashiwagi, Kengo Shigehara, Terufumi Kubo, et al.
Cancer Science|December 31, 2017
C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironmentSatoko Urata, Kouji Izumi, Kaoru Hiratsuka, et al.
Journal of Cardiology Cases|September 12, 2022
Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imagingKazuoki Dai, Kuniomi Oi, Yohei Hyodo, et al.
Pageof 38

Showing results (331-340 of 378) with videos related to

Sort By:
Pageof 38
Biomedicines|February 24, 2024
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate CancerHiroshi Kano, Kouji Izumi, Ryunosuke Nakagawa, et al.
Journal of Medical Virology|December 25, 2010
Etiological role of human papillomavirus infection for inverted papilloma of the bladderKazuyoshi Shigehara, Toshiyuki Sasagawa, John Doorbar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 14, 2018
Etiological role of human papillomavirus infection in the development of penile cancerJiro Sakamoto, Kazuyoshi Shigehara, Kazufumi Nakashima, et al.
Urology Journal|December 20, 2021
Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECISTYoshifumi Kadono, Shohei Kawaguchi, Takahiro Nohara, et al.
Cancers|October 14, 2022
Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese MenRyunosuke Nakagawa, Hiroaki Iwamoto, Tomoyuki Makino, et al.
Anticancer Research|March 31, 2021
Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial CarcinomaYoshifumi Kadono, Shohei Kawaguchi, Takahiro Nohara, et al.
Cancers|February 9, 2020
Reply to Comment on "Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis" Cancers 2020 12, 89Suguru Kadomoto, Kouji Izumi, Kaoru Hiratsuka, et al.
Medical Molecular Morphology|March 14, 2025
Large number of CD68<sup>+</sup>/CD163<sup>+</sup> Hofbauer cells and characteristic vascular structural alterations in the placental villi of cases with placenta accreta spectrumHazuki Kashiwagi, Kengo Shigehara, Terufumi Kubo, et al.
Cancer Science|December 31, 2017
C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironmentSatoko Urata, Kouji Izumi, Kaoru Hiratsuka, et al.
Journal of Cardiology Cases|September 12, 2022
Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imagingKazuoki Dai, Kuniomi Oi, Yohei Hyodo, et al.
Pageof 38